October 8, 2026- Medela announced the expansion of Drainology™, a scientific initiative dedicated to advancing evidence-based chest drain management through research, education and clinical collaboration. With new digital channels, expert-led educational resources and scientific events, the initiative will broaden access to knowledge and create additional opportunities for exchange and collaboration across the global healthcare community.
Drainology™ will also be featured as part of Medela’s presence at the 40th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting, taking place October 7–10, 2026, in Barcelona, Spain.
Although chest drainage therapy is a fundamental component of cardiothoracic care, clinical practice continues to vary across healthcare settings. Drainology™ aims to support healthcare professionals by providing an evidence-based platform for education, expert dialogue, and practical insights.
Guided by an independent scientific board and sponsored by Medela, Drainology™ was established to encourage scientific exchange, promote evidence-based approaches, and help translate emerging knowledge into clinical practice.
Through Drainology™, Medela reinforces its commitment to clinical excellence in chest drainage therapy by supporting the generation, dissemination and application of scientific evidence. It serves as a global resource for clinicians who seek to strengthen decision-making, reduce practice variability and improve patient outcomes.